Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: Causes and management

Journal of Otolaryngology

Volumn 30, Issue 6, 2001, Pages 324-329

  Brook, Itzhak ^a  

^a NONE   (United States)

Author keywords

Beta lactamase; Group A beta hemolytic streptococci; Interference; Penicillin; Tonsillitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFADROXIL; CEFALEXIN; CEFDINIR; CEFPROZIL; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME SYNTHESIS; ERADICATION THERAPY; HUMAN; INTERNALIZATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REINFECTION; STREPTOCOCCUS GROUP A; TONSILLITIS; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 0035728640     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2001.19359     Document Type: Article

References (36)

1. The resurgence of group A streptococcal infections and their sequelae
2. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection
3. Bacterial interference: I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci
4. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus
5. Bacterial interference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci
6. Bacterial interference IV: Epidemiologic determinants of the antagonistic activity of the normal throat flora against group A streptococci
7. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment
8. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: Effect on the recovery of penicillin-resistant bacteria from children
9. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci
10. Possible role of the anaerobe in tonsillitis
11. β-lactamase-producing anaerobic bacteria in recurrent tonsillitis
12. Flora indigena de las amigdales
13. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis
14. Effect of penicillin or cefprozil therapy on tonsillar flora
15. Quantitative measurement of β-lactamase level in tonsils of children with recurrent tonsillitis
16. The role of bacterial antagonism in pneumococcal colonization of the human pharynx
17. Bacterial interference among strains of Staphylococcus aureus in man
18. Treatment of recurrent streptococcal tonsillitis by recolonization with alpha-streptococci
19. Experimental infection of the skin in the hamster simulating human impetigo. III. Interaction between staphylococci and group A streptococci
20. Viridins, enteriocins of alpha-hemolytic streptococci: Isolation, characterization, and partial purification
21. Interference by an alpha hemolytic streptococcus of beta-hemolytic pathogenic streptococci
22. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area
23. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis
24. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis
25. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent group A beta-hemolytic streptococcal tonsillitis
26. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children
27. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis - A randomized placebo-controlled study
28. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis - A randomized placebo-controlled multicentre study
29. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis
30. Evaluation of bacterial interference and beta-lactamase production in the management of experimental infection with group A beta-hemolytic streptococci
31. Antibacterial activity of ceftibuten, a new oral third generation cephalosporin
32. A comparison of cephalosporins and penicillins in the treatment of group A β-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity
33. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis
34. Group A beta-hemolytic Streptococcus: Issue of resistance
35. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA
36. Streptococcal pharyngitis: The carrier state, definition, and management